@article{Agrawal_U-2022_98724,
title = {Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales},
author = {Agrawal, U. and Bedston, S. and McCowan, C. and Oke, J. and Patterson, L. and Robertson, C. and Akbari, A. and Azcoaga-Lorenzo, A. and Bradley, D. and Fagbamigbe, A. and Grange, Z. and Hall, E. and Joy, M. and Katikireddi, S. and Kerr, S. and Ritchie, L. and Murphy, S. and Owen, R. and Rudan, I. and Shah, S. and Simpson, C. and Torabi, F. and Tsang, R. and de Lusignan, S. and Lyons, R. and O'Reilly, D. and Sheikh, A.},
month = {oct},
year = {2022},
abstract = {Current UK vaccination policy is to offer future COVID-19 booster doses to individuals at high risk of serious illness from COVID-19, but it is still uncertain which groups of the population could benefit most. In response to an urgent request from the UK Joint Committee on Vaccination and Immunisation, we aimed to identify risk factors for severe COVID-19 outcomes (ie, COVID-19-related hospitalisation or death) in individuals who had completed their primary COVID-19 vaccination schedule and had received the first booster vaccine.},
pages = {1305-1320},
volume = {400},
issue = {10360},
journal = {The Lancet},
publisher = {Elsevier},
url = {https://doi.org/10.1016/S0140-6736},
}
